Bioceres Crop Solutions | BIOX | Long at $1.43Technical Analysis
Bioceres Crop Solutions NASDAQ:BIOX has entered my selected "crash" simple moving average. This area is often a zone of share accumulation and may result in a trend reversal (or a short-term stair-step down to $1 or lower before trading sideways).
Growth, Fundamentals, & Health
Not expected to become profitable again until 2028.
Earnings-per-shares growth from 2026 (-$0.26) to 2028 ($0.56): +323%
Revenue growth from 2026 ($350 million) to 2028 ($511 million): +46%
Current Fair Value: $5
Debt-to-Equity: 0.9x (very good / healthy)
Altman's Z-Score/Bankruptcy Risk: .9 (high risk, some financial distress)
Action
75% technical analysis play and only 25% based on company fundamentals. The only major risk based on the data is bankruptcy. The near-term could be rough for the company, but the outlook into 2028 shows significant growth. Thus, at $1.43, NASDAQ:BIOX is in a personal buy zone. There could be near-term risk near $1 or a bit lower, but this one is a total gamble. Time will tell.
Targets into 2028
$2.00 (+39.9%)
$4.00 (+179.7%)
